TAG:
LIS
Tactics to Standardize Point-of-Care Testing
By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue
CEO SUMMARY: Managing point-of-care testing (POCT) at a multi-hospital health system like Johns Hopkins Medicine (JHM) often means overseeing thousands of nurses and staff members who perform such tests. Lessons learned at JHM in standardizing POCT, training staff, and maintaining q…
Oracle’s Plans for Cerner Might Increase Value of Lab Test Data
By Robert Michel | From the Volume XXIX, Number 9 – June 27, 2022 Issue
ONE MAJOR INFORMATICS PLAYER HAS AMBITIOUS PLANS that could make diagnostic data more accessible and, at the same time, more valuable for clinical laboratories. Oracle, the new owner of Cerner Corporation, is telling financial analysts that it wants to create a national repository of h…
U.K.-based CliniSys Acquires Nashville-based ApolloLIMS
By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue
CONSOLIDATION IN THE CLINICAL LABORATORY INFORMATICS INDUSTRY took another step forward with the announcement that CliniSys (the parent of Sunquest Information Systems) was acquiring Nashville-based ApolloLIMS. This move may also further muddy the line between classic laborato…
March 14, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 4 – March 14, 2022 Issue
Telehealth proved to be popular with Medicare patients during the SARS-CoV-2 pandemic. The federal U.S. Department of Health and Human Services (HHS) reported telehealth visits for Medicare beneficiaries increased in 2020 by an incredible 63 times—from approximately 840,000 in 2019 to 52.7 m…
LIS Pioneer and Entrepreneur Sidney Goldblatt, MD, Dies at 87
By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue
IN THE 1970S, THE ARRIVAL OF AUTOMATED LAB ANALYZERS—such as the Technicon …
LIS Market Will Change After Oracle and CliniSys Acquisitions
By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue
This is an excerpt of a 843-word article in the January 31, 2022 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: The Oracle and CliniSys acquisitions will create major changes. With its purchase of Cerner Corpo…
Witness the Land Grab to Control Healthcare Data
By R. Lewis Dark | From the Volume XXIX, No. 2 – January 31, 2022 Issue
LIKE MOST OF YOU, IT CERTAINLY CAUGHT MY ATTENTION WHEN I LEARNED in December that Oracle will pay $28 billion—with a B!—to buy Cerner Corporation. I don’t question the value of Cerner’s products; the company has an EHR product tha…
LIS Market Will Change After Oracle, CliniSys Deals
By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue
CEO SUMMARY: With its purchase of Cerner Corporation, Oracle becomes the owner of Cerner’s Millennium laboratory information system (LIS) and CoPathPlus, Cerner’s anatomic pathology LIS. Only three weeks later, CliniSys, a division of Roper Technologies, announced it was acquiri…
Oracle’s $28b Cerner Deal Shows Value of Health Data
By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue
CEO SUMMARY: For three decades, pathologists and clinical lab executives regularly pointed out that clinical laboratory data was extremely valuable. But it seemed nothing changed, no one listened, and labs could not monetize their lab data. Now, one of Silicon Valley’s bigger play…
More LIS Consolidation as CliniSys Buys Horizon Lab
By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue
CEO SUMMARY: By acquiring Horizon Lab Systems, CliniSys has committed to moving some of its services beyond the clinical laboratory as Horizon sells into other lab markets, such as environmental management. Also, CliniSys will combine with Sunquest Information Systems,…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized